Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2

Journal of Virology
Yonggang PeiErle S Robertson

Abstract

Cell cycle regulation is one of the hallmarks of virus-mediated oncogenesis. Epstein-Barr virus (EBV)-induced lymphomas express a repertoire of essential viral latent proteins that regulate expression of cell cycle-related proteins to dysregulate this process, thereby facilitating the proliferation of infected cells. We now demonstrate that the essential EBV latent protein 3C (EBNA3C) stabilizes cyclin D2 to regulate cell cycle progression. More specifically, EBNA3C directly binds to cyclin D2 and they colocalize together in nuclear compartments. We show that EBNA3C regulates the promoter of cyclin D2 through cooperation with master transcription factor Bcl6 and enhances its stability by inhibiting its ubiquitin-dependent degradation. EBNA3C also promoted cell proliferation in the presence of cyclin D2, suggesting that cyclin D2 contributes to EBNA3C-mediated cell cycle progression. These results provide new clues as to the role of this essential viral latent protein and its ability to regulate expression of cellular factors, which drives the oncogenic process.IMPORTANCE Epstein-Barr virus (EBV) is the first identified human tumor virus and is associated with a range of human cancers. During EBV-induced lymphomas, the essential...Continue Reading

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J I CohenE Kieff
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K M KayeE Kieff
Nov 1, 1996·Molecular Biology of the Cell·S ElsasserA Jong
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A EzhevskyS F Dowdy
May 4, 1999·International Journal of Cancer. Journal International Du Cancer·N TeramotoG Klein
Oct 6, 2000·Genes & Development·J W Harbour, D C Dean
Feb 14, 2002·Critical Reviews in Oncology/hematology·Alexander L DentLisa M Toney
Dec 17, 2002·Critical Reviews in Oncology/hematology·Jaap M MiddeldorpChris J L M Meijer
Jul 13, 2004·The Journal of Investigative Dermatology·Naoko Kanda, Shinichi Watanabe
Oct 29, 2004·Molecular and Cellular Biology·Silvia Fernández de MattosEric W-F Lam
Dec 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jason S KnightErle S Robertson
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Seiji MaruoKenzo Takada
Dec 24, 2009·Nature Reviews. Cancer·Thomas SantariusColin S Cooper
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jul 8, 2011·Nature Reviews. Cancer·Elizabeth A MusgroveRobert L Sutherland
Apr 17, 2012·Immunological Reviews·Katia Basso, Riccardo Dalla-Favera
Dec 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sizun JiangBo Zhao
Mar 22, 2014·Science·Paul M Lieberman
Dec 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Stefanie C S SchmidtBo Zhao
Nov 4, 2016·Nature Reviews. Cancer·Lawrence S YoungPaul G Murray
Nov 9, 2016·Frontiers in Microbiology·Hem C JhaErle S Robertson
Oct 21, 2017·Advances in Experimental Medicine and Biology·Yonggang PeiErle S Robertson

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.